Hypertension-Focused Medication Therapy Management: A Collaborative Pilot Program Uniting Pharmacists, Public Health, and Health Insurers in Wisconsin.

Hypertension-Focused Medication Therapy Management: A Collaborative Pilot Program Uniting Pharmacists, Public Health, and Health Insurers in Wisconsin.
复制标题

以高血压为中心的药物治疗管理:威斯康星州药剂师、公共卫生和健康保险公司联合的合作试点项目。

DOI:
10.5888/pcd17.200058
复制
发表时间:
2020-09-10
影响因子:
5.5
通讯作者:
Trapskin K
Trapskin K
中科院分区:
医学3区
文献类型:
--
作者:
Thompson H;Swander L;Cohen R;Lukazewski A;Bartholow T;Pesik M;Trapskin K

文献摘要

参考文献

相似文献

心脏病和中风是美国死亡和残疾的主要原因,高血压是两者的主要危险因素。社区药剂师很容易通过药物治疗管理和自我管理教育等服务来改善心血管健康。2018年,威斯康星州药学会、威斯康星州公共卫生部和非营利健康保险公司NeuGen与8家社区药店合作,为高血压患者试行了一项由药剂师主导的药物治疗管理计划。我们评估了药物治疗管理服务前后血压自我管理工具使用的变化和抗高血压药物依从性的障碍。在项目结束时,还对59名参与者进行了参与者满意度评估。我们观察到自我报告的自我管理工具的使用有所改善,药物依从性障碍减少,对药剂师护理的满意度较高。这一合作试点为参与的药房提供了可持续的报销,这些药房为符合条件的NeuGen成员提供药物治疗管理服务。
Heart disease and stroke are leading causes of death and disability in the United States, and high blood pressure is a major risk factor for both. Community pharmacists are readily positioned to improve cardiovascular health through services such as medication therapy management and self-management education. In 2018, the Pharmacy Society of Wisconsin, the Wisconsin Division of Public Health, and NeuGen, a not-for-profit health insurer, piloted a pharmacist-led medication therapy management program for people with hypertension in partnership with 8 community pharmacies. We evaluated changes in use of blood pressure self-management tools and barriers to antihypertensive medication adherence before and after medication therapy management services. Participant satisfaction was also assessed for the 59 participants at the end of the program. We observed improvements in self-reported use of self-management tools, reductions in medication adherence barriers, and high satisfaction with pharmacist care. This collaborative pilot resulted in sustainable reimbursement for participating pharmacies delivering medication therapy management services to eligible NeuGen members.
DOI: 10.1001/jama.299.24.2857
发表时间: 2008-06-25
影响因子: 120.7
作者:
Green, Beverly B.;Cook, Andrea J.;Thompson, Robert S.
通讯作者: Thompson, Robert S.
DOI: 10.1111/j.1525-1497.2005.0226.x
发表时间: 2005-12-01
影响因子: 5.7
作者:
Zillich, AJ;Sutherland, JM;Carter, BL
通讯作者: Carter, BL
DOI: 10.1592/phco.20.17.1384.34891
发表时间: 2000-11-01
期刊: PHARMACOTHERAPY
影响因子: 4.1
作者:
Mehos, BM;Saseen, JJ;MacLaughlin, EJ
通讯作者: MacLaughlin, EJ
DOI: 10.1016/s0738-3991(98)00107-4
发表时间: 1999-06-01
影响因子: 3.5
作者:
Svarstad, BL;Chewning, BA;Claesson, C
通讯作者: Claesson, C